Teens with type 1 diabetes: counting protein and fat may improve blood sugar control
NCT ID NCT07158385
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether counting protein and fat, in addition to carbohydrates, helps control blood sugar after meals in adolescents with type 1 diabetes. Eleven teens using insulin pumps ate standard and high-fat-high-protein meals, and their blood sugar, hormones, and fatty acids were tracked for 6 hours. The goal was to see if adjusting insulin for all nutrients improves post-meal glucose levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Standard meal and high-fat-high-protein meals with different insulin dosing strategies
- What this could lead to
- If successful, this could lead to better insulin dosing guidelines that account for protein and fat, helping teens with type 1 diabetes manage blood sugar after meals.
- What could go wrong
- This was a small, completed study with only 11 participants, so results may not apply to everyone. It was also a single-center trial, limiting generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
11 people
The number who actually took part.
- Started
-
Jan 2019
- Finished
-
Feb 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * No chronic disease other than type 1 diabetes mellitus * Receiving continuous insulin infusion pump therapy Exclusion Criteria: * The individual's insulin requirement is less than 0.5 IU/kg/day * High HbA1c (\>8%) * Presence of complications (Microalbuminuria, etc.) * Presence of a comorbidity (Celiac disease, etc.) * New initiation of CSII treatment (\<6 months) * Living outside Ankara * Parental and individual reluctance * The individual refuses to donate blood during the test meals
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adolescent are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sivas Cumhuriyet University, Faculty of Health Sciences, Department of Nutrition and Dietetics
Sivas, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy aims to free type 1 diabetics from insulin shots
- Muscle-Injected gene therapy aims to help type 1 diabetes control blood sugar
- Can a glucose sensor and family coaching tame type 1 diabetes in toddlers?
- Can a smartphone app help heal diabetic foot wounds?
- Can a handoff plan help teens with chronic illness take charge of their care?
- Cheap blood test could flag diabetic kidney damage before it strikes